1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects

Healthy Subjects ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Neutralizing Monoclonal Antibody ◽

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.883 ◽

2020 ◽

Author(s):

Antonios O. Aliprantis ◽

Dennis Wolford ◽

Luzelena Caro ◽

Brian M. Maas ◽

Hua Ma ◽

...

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Neutralizing Monoclonal Antibody ◽

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-ESCALATION TRIAL OF A HUMANIZED RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL ANTIBODY (MEDI-493) IN HIGH RISK INFANTS. • 768

Pediatric Research ◽

10.1203/00006450-199704001-00788 ◽

1997 ◽

Vol 41 ◽

pp. 130-130

Author(s):

K. N. Siva Subramanian ◽

L. Weisman ◽

T. Rhodes ◽

E. Connor

Keyword(s):

Monoclonal Antibody ◽

High Risk ◽

Dose Escalation ◽

Double Blind ◽

Double Blind Placebo ◽

Syncytial Virus ◽

High Risk Infants

The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial

Yearbook of Pediatrics ◽

10.1016/s0084-3954(09)79553-3 ◽

2011 ◽

Vol 2011 ◽

pp. 504-506

Author(s):

J.A. Stockman

Keyword(s):

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Inhaled Corticosteroids ◽

Controlled Trial ◽

High Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(15)00247-9 ◽

2015 ◽

Vol 15 (12) ◽

pp. 1398-1408 ◽

Cited By ~ 98

Author(s):

Katherine L O'Brien ◽

Aruna Chandran ◽

Robert Weatherholtz ◽

Hasan S Jafri ◽

M Pamela Griffin ◽

...

Keyword(s):

Native American ◽

Virus Disease ◽

Controlled Trial ◽

Respiratory Syncytial Virus Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy of Motavizumab for the Prevention of Respiratory Syncytial Virus Disease in Healthy Native American Infants: A Phase 3 Randomised Double-blind Placebo-controlled Trial

Journal of the Pediatric Infectious Diseases Society ◽

10.1093/jpids/piv087 ◽

2016 ◽

Vol 5 (1) ◽

pp. 93-95

Author(s):

Rana F. Hamdy

Keyword(s):

Native American ◽

Virus Disease ◽

Controlled Trial ◽

Respiratory Syncytial Virus Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

Thorax ◽

10.1136/thx.52.7.634 ◽

1997 ◽

Vol 52 (7) ◽

pp. 634-637 ◽

Cited By ~ 77

Author(s):

J. B. van Woensel ◽

T. F. Wolfs ◽

W. M. van Aalderen ◽

P. L. Brand ◽

J. L. Kimpen

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Respiratory Syncytial Virus Bronchiolitis ◽

Phase I/II, Double-blind, Placebo-controlled, Multi-dose Escalation Trial of a Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody (MEDI-493) in Children Hospitalized with RSV • 906

Pediatric Research ◽

10.1203/00006450-199804001-00927 ◽

1998 ◽

Vol 43 ◽

pp. 156-156 ◽

Cited By ~ 5

Author(s):

Xavier Saez-Llorens ◽

Maria T Moreno ◽

Octavio Ramilo ◽

Pablo J Sanchez ◽

Edward M Connor

Keyword(s):

Monoclonal Antibody ◽

Phase I ◽

Dose Escalation ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725888977.793559350 ◽

2019 ◽

Author(s):

Fernando Polack

Keyword(s):

Native American ◽

Virus Disease ◽

Controlled Trial ◽

Respiratory Syncytial Virus Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Dexamethasone in Severe Respiratory Syncytial Virus (RSV) Infection: Effects on RSV Quantity and Clinical Outcome

The Journal of Infectious Diseases ◽

10.1086/340024 ◽

2002 ◽

Vol 185 (9) ◽

pp. 1222-1228 ◽

Cited By ~ 70

Author(s):

Steven C. Buckingham ◽

Hasan S. Jafri ◽

Andrew J. Bush ◽

Cecilia M. Carubelli ◽

Paul Sheeran ◽

...

Keyword(s):

Clinical Outcome ◽

Controlled Trial ◽

Severe Respiratory Syncytial Virus ◽

Double Blind ◽

Double Blind Placebo ◽

Rsv Infection ◽

Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.

Archives of Disease in Childhood ◽

10.1136/adc.63.8.986 ◽

1988 ◽

Vol 63 (8) ◽

pp. 986-990 ◽

Cited By ~ 11

Author(s):

D Isaacs ◽

E R Moxon ◽

D Harvey ◽

I Kovar ◽

C R Madeley ◽

...

Keyword(s):

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽